Immunovant (IMVT) Other Gross PP&E Adjustments (2019 - 2026)
Immunovant filings provide 7 years of Other Gross PP&E Adjustments readings, the most recent being -$13.7 million for Q1 2025.
- Quarterly Other Gross PP&E Adjustments fell 48.66% to -$13.7 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$13.7 million through Mar 2025, down 48.66% year-over-year, with the annual reading at -$13.7 million for FY2025, 48.66% down from the prior year.
- Other Gross PP&E Adjustments hit -$13.7 million in Q1 2025 for Immunovant, down from -$22000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$22000.0 in Q4 2024 and bottomed at -$13.7 million in Q1 2025.
- Average Other Gross PP&E Adjustments over 5 years is -$3.6 million, with a median of -$2.0 million recorded in 2022.
- The largest annual shift saw Other Gross PP&E Adjustments tumbled 328.88% in 2021 before it skyrocketed 92.52% in 2024.
- Immunovant's Other Gross PP&E Adjustments stood at -$2.5 million in 2021, then soared by 40.5% to -$1.5 million in 2022, then skyrocketed by 79.85% to -$294000.0 in 2023, then skyrocketed by 92.52% to -$22000.0 in 2024, then crashed by 62359.09% to -$13.7 million in 2025.
- Per Business Quant, the three most recent readings for IMVT's Other Gross PP&E Adjustments are -$13.7 million (Q1 2025), -$22000.0 (Q4 2024), and -$45000.0 (Q3 2024).